TY - CHAP M1 - Book, Section TI - Lidocaine A1 - Bauer, Larry A. Y1 - 2015 N1 - T2 - Applied Clinical Pharmacokinetics, 3e AB - Lidocaine is a local anesthetic agent that also has antiarrhythmic effects. It is classified as a type IB antiarrhythmic agent and is a treatment for ventricular tachycardia.1,2 For episodes of sustained ventricular tachycardia with signs or symptoms of hemodynamic instability (angina, pulmonary edema, hypotension, hemodynamic collapse), electrical cardioversion is the treatment of choice. However, for patients who are hemodynamically stable, sustained monomorphic ventricular tachycardia may be successfully treated using antiarrhythmic therapy. Lidocaine therapy is considered an alternative to procainamide, amiodarone, or sotalol treatment in this situation.3 SN - PB - McGraw-Hill Medical CY - New York, NY Y2 - 2024/03/28 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1115557286 ER -